Impact of new clinical laboratory standards institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time

Microbial Drug Resistance

Volumn 17, Issue 1, 2011, Pages 47-52

  Mera, Robertino M ^a   Miller, Linda A ^a   Amrine Madsen, Heather ^a   Sahm, Daniel F ^b  

^a GLAXOSMITHKLINE   (United States)

^b Eurofins Medinet Inc   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD; BRONCHUS; CEREBROSPINAL FLUID; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; LABORATORY TEST; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STANDARD; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DATABASES AS TOPIC; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; UNITED STATES;

STREPTOCOCCUS PNEUMONIAE;

EID: 79952408916     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2010.0129     Document Type: Article

References (14)

1. Ambrose, P., W. Craig, S. Bhavani, and M. Dudley. 2002. Pharmacodynamic comparisons of different dosing regimens of penicillin G against penicillin-susceptible and-resistant pneumococci [abstract A-1263]. In: Program and Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). American Society for Microbiology, Washington, DC.
2. Clinical and Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI Document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Fedson, D., J. Scott, and G. Scott. 1999. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 17: S11-S18. (Pubitemid 29366927)
4. File, T. 2002. Appropriate use of antimicrobials for drug resistant pneumonia: focus on the significance of betalactam-resistant Streptococcus pneumoniae. Clin. Infect. Dis. Suppl 1:17-26.
5. File, T., Jr., J. Tan, and J. Boex. 2006. The clinical relevance of penicillin-resistant Streptococcus pneumoniae: a new perspective. Clin. Infect. Dis. 42:798-800. (Pubitemid 43363935)
6. Mera, R. M., L. Miller, H. Amrine-Madsen, and D. Sahm. 2009. The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the united states since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics. Microb. Drug Resist. 15:261-268.
7. Mera, R. M., L. Miller, T. Fritsche, and R. Jones. 2008. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb. Drug Resist. 14:101-107.
8. Musher, D., J. Bartlett, and G. Doern. 2001. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch. Intern. Med. 161:2538-2544.
9. Palleres, R., J. Linares, M. Vadillo, C. Cabellos, F. Manresa, and P. Viladrich. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
10. Peterson, L. 2006. Penicillins for the treatment of pneumococcal pneumonia: does in vitro resistance really matter? Clin. Infect. Dis. 42:224-233. (Pubitemid 43054194)
11. Robinson, K., W. Baughman, G. Rothrock, and C. Whytney. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 285:1729-1735. (Pubitemid 32259907)
12. Tleyjeh, I. M., H. Tlaygeh, R. Hejal, V. Montori, and L. Baddour. 2006. The impact of penicillin resistance on shortterm mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin. Infect. Dis. 42:788-797. (Pubitemid 43363934)
13. Weinstein, M. P., K. Klugman, and R. Jones. 2009. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era or resistance. Clin. Infect. Dis. 48:1596-1600.
14. Yu, V. L., C. Chiou, C. Feldman, A. Ortqvist, J. Rello, A. Morris, L. Baddour, C. Luna, D. Snydman, and K. Klugman. 2003. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. International Pneumococcal Study Group. Clin. Infect. Dis. 37:230-237. (Pubitemid 36930354)